Long-term Outcomes Associated With Juvenile-onset Mycosis Fungoides and Lymphomatoid Papulosis
Launched by M.D. ANDERSON CANCER CENTER · Jan 5, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking into the long-term effects of two skin conditions called juvenile-onset mycosis fungoides and lymphomatoid papulosis in young patients. The goal is to follow up with individuals diagnosed with these conditions before they turned 20 years old. Researchers want to check on how these conditions have affected their lives over time, gathering insights directly from the participants or their parents if they are still minors.
To participate in this study, individuals must have been diagnosed with either of these conditions before the age of 20. If the participant is under 18, their parents will be contacted to help answer the study questions since the children themselves are not involved. This trial is currently recruiting participants of any gender, and it aims to understand the long-term outcomes for those who have lived with these skin disorders. Participants can expect to share their experiences and health status, contributing valuable information that may help others in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • -To be eligible, participants had to be diagnosed with jMF or lyp before age 20. In the case of participants below the age of 18, parents and not the children will be contacted for participation (children are exempt from participation as their parents may answer our study questions).
- Exclusion Criteria:
- • -Participants older than 20 years of age at diagnosis
About M.D. Anderson Cancer Center
The University of Texas MD Anderson Cancer Center is a leading institution dedicated to cancer care, research, education, and prevention. As one of the world’s most respected cancer centers, MD Anderson focuses on innovative treatment approaches and groundbreaking clinical trials aimed at improving patient outcomes. With a multidisciplinary team of experts and state-of-the-art facilities, the center is committed to advancing cancer research and providing comprehensive, personalized care to patients. MD Anderson's clinical trials play a pivotal role in translating scientific discoveries into effective therapies, positioning the center at the forefront of cancer treatment and research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Houston, Texas, United States
Houston, Texas, United States
Patients applied
Trial Officials
Julia Dai, MD
Principal Investigator
M.D. Anderson Cancer Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported